| Non-coding RNA generated following lariat debranching mediates targeting of AID to DNA S Zheng, BQ Vuong, B Vaidyanathan, JY Lin, FT Huang, J Chaudhuri Cell 161 (4), 762-773, 2015 | 205 | 2015 |
| The aryl hydrocarbon receptor controls cell-fate decisions in B cells B Vaidyanathan, A Chaudhry, WT Yewdell, D Angeletti, WF Yen, ... Journal of Experimental Medicine 214 (1), 197-208, 2017 | 102 | 2017 |
| Antagonistic actions of Rcor proteins regulate LSD1 activity and cellular differentiation G Upadhyay, AH Chowdhury, B Vaidyanathan, D Kim, S Saleque Proceedings of the National Academy of Sciences 111 (22), 8071-8076, 2014 | 73 | 2014 |
| A DNA break–and phosphorylation-dependent positive feedback loop promotes immunoglobulin class-switch recombination BQ Vuong, K Herrick-Reynolds, B Vaidyanathan, JN Pucella, AJ Ucher, ... Nature immunology 14 (11), 1183-1189, 2013 | 69 | 2013 |
| Long-term programming of CD8 T cell immunity by perinatal exposure to glucocorticoids JY Hong, J Lim, F Carvalho, JY Cho, B Vaidyanathan, S Yu, C Annicelli, ... Cell 180 (5), 847-861. e15, 2020 | 63 | 2020 |
| AIDing chromatin and transcription-coupled orchestration of immunoglobulin class-switch recombination B Vaidyanathan, WF Yen, JN Pucella, J Chaudhuri Frontiers in immunology 5, 120, 2014 | 37 | 2014 |
| A hyper-IgM syndrome mutation in activation-induced cytidine deaminase disrupts G-quadruplex binding and genome-wide chromatin localization WT Yewdell, Y Kim, P Chowdhury, CM Lau, RM Smolkin, KT Belcheva, ... Immunity 53 (5), 952-970. e11, 2020 | 27 | 2020 |
| Tissue remodeling by an opportunistic pathogen triggers allergic inflammation K Agaronyan, L Sharma, B Vaidyanathan, K Glenn, S Yu, C Annicelli, ... Immunity 55 (5), 895-911. e10, 2022 | 21 | 2022 |
| Epigenetic codes programing class switch recombination B Vaidyanathan, J Chaudhuri Frontiers in immunology 6, 155484, 2015 | 18 | 2015 |
| Distinct requirements of CHD4 during B cell development and antibody response WF Yen, R Sharma, M Cols, CM Lau, A Chaudhry, P Chowdhury, ... Cell reports 27 (5), 1472-1486. e5, 2019 | 11 | 2019 |
| Induction of natural IgE by glucocorticoids J Lim, EV Lin, JY Hong, B Vaidyanathan, SA Erickson, C Annicelli, ... Journal of Experimental Medicine 219 (10), e20220903, 2022 | 6 | 2022 |
| BRCT-domain protein BRIT1 influences class switch recombination WF Yen, A Chaudhry, B Vaidyanathan, WT Yewdell, JN Pucella, ... Proceedings of the National Academy of Sciences 114 (31), 8354-8359, 2017 | 6 | 2017 |
| Preclinical evidence for the glucocorticoid-sparing potential of a dual toll-like receptor 7/8 inhibitor in autoimmune diseases A Deshmukh, A Pereira, N Geraci, E Tzvetkov, M Przetak, MD Catalina, ... Journal of Pharmacology and Experimental Therapeutics 388 (3), 751-764, 2024 | 2 | 2024 |
| LP-183 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and phase II study design in patients with SLE and/or CLE (WILLOW) EF Morand, VP Werth, A Bender, A Deshpande, A Deshmukh, ... Lupus Science & Medicine 10 (Suppl 1), 2023 | | 2023 |
| POS1413 PRECLINICAL EVIDENCE FOR THE GLUCOCORTICOID-SPARING POTENTIAL OF A DUAL TLR7/8 INHIBITOR IN AUTOIMMUNE DISEASES A Deshmukh, A Pereira, N Geraci, E Tzvetkov, M Przetak, M Catalina, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 1060-1061, 2023 | | 2023 |
| 1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW) EF Morand, VP Werth, A Bender, A Deshpande, A Deshmukh, ... Lupus Science & Medicine 9 (Suppl 3), 2022 | | 2022 |
| AB0444 ENPATORAN: PRECLINICAL EVIDENCE SUPPORTING GLUCOCORTICOID DOSE REDUCTION AND PHASE II STUDY DESIGN IN PATIENTS WITH SLE AND/OR CLE (WILLOW) EF Morand, A Bender, A Deshpande, B Vaidyanathan, CV Mateo, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 1350-1351, 2022 | | 2022 |
| Abstract B162: Developmental programming of long-term immunity of CD8 T-cells by perinatal glucocorticoids JY Hong, B Vaidyanathan, JY Cho, R Medzhitov Cancer Immunology Research 7 (2_Supplement), B162-B162, 2019 | | 2019 |
